Inactive Instrument

Highlights Chembio Diagnostics, Inc. OTC Bulletin Board

Equities

CEMI

US1635722093

Highlights

Unlock all the news: Be the first to know and act before the market!

Chembio Diagnostics, Inc. acquired FastPack® diagnostics business from Qualigen Therapeutics, Inc. for $5.8 million.	23/07/23	CI
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.	26/04/23	CI
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23	CI
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23	CI
Biosynex: takeover bid extended for Chembio Diagnostics	29/03/23	CF
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises	29/03/23	MT
Chembio Announces Receipt of CLIA Waiver for its DPP HIV-Syphilis System	24/02/23	CI
Chembio Diagnostics Agrees to $17.2 Million Takeover by Biosynex; Shares Rise Pre-Bell	01/02/23	MT
Biosynex SA entered into a definitive merger agreement to acquire Chembio Diagnostics, Inc. for $17.2 million.	30/01/23	CI
Chembio Diagnostics Applies to FDA for CLIA Waiver for DPP HIV-Syphilis System	28/11/22	MT
Chembio Diagnostics, Inc. Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System	28/11/22	CI
Earnings Flash (CEMI) CHEMBIO DIAGNOSTICS Posts Q3 Revenue $11.2M	03/11/22	MT
Earnings Flash (CEMI) CHEMBIO DIAGNOSTICS Posts Q3 Loss $-0.21	03/11/22	MT
Chembio Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/11/22	CI
Chembio Diagnostics Wins $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay	06/09/22	CI
Chembio Diagnostics Mulling Development of Monkeypox Rapid Test; Shares Rise	16/08/22	MT
Earnings Flash (CEMI) CHEMBIO DIAGNOSTICS Reports Q2 Loss $-0.23	04/08/22	MT
Earnings Flash (CEMI) CHEMBIO DIAGNOSTICS Reports Q2 Revenue $9.2M	04/08/22	MT
Earnings Flash (CEMI) CHEMBIO DIAGNOSTICS Reports Q2 Loss $-0.23	04/08/22	MT
Chembio Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/08/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chembio Diagnostics, Inc. OTC Bulletin Board

Equities

CEMI

US1635722093

Highlights

Filters